Here is the news:
A research team from East China Normal University in Shanghai developed an engineered oral-deliverable glucose-sensing and functional response probiotic (GIFT) living drug for "sense-and-respond"-based control of diabetic blood glucose, marking a brand-new approach for diabetes treatment.
The research was conducted by researchers from the university's School of Life Sciences, and the findings were published in the journal Nature on Aug 12.
Using synthetic biology techniques, the research team engineered a probiotic with a century-long history of safety into an "intelligent virtual organ" that can be taken orally and reside temporarily in the intestine. It can sense blood glucose fluctuations in real time and autonomously secrete glucose-lowering hormones, enabling therapeutic dosing in response to real-time blood glucose levels, and providing a programmable, orally deliverable sense-and-respond platform for metabolic therapy without transplantation.
This approach shifts diabetes blood glucose management from the traditional passive model of injections and medication to a new paradigm of "oral implantation and autonomous regulation", achieving true on-demand drug delivery and physiological-level closed-loop control.
MY COMMENTS: Hello Menteri Kesihatan the Chinese are introducing new treatments and new medicines for diseases, sometimes there is one new drug or treatment every week.
Is the Kementerian Kesihatan keeping up with these latest developments in China? I suggest the Kementerian set up a Chinese Pharmacology and Medical Sciences department whose main task should be to study and keep track of all the latest medical and health discoveries being made in China and how we can bring these new discoveries into Malaysia for the benefit of our people.
Now the Chinese are also an acknowledged world leader in the treatment of cancers. They are marketing (already available in their pharmacies) brand new cancer drugs that are helping cancer patients.
China's Growing Importance in Global Cancer Medicines. China has transformed from a generic drug manufacturer into a primary global engine for innovative oncology research and development. Propelled by sweeping 2015 regulatory reforms, massive out-licensing deals, and deep engineering capabilities, Chinese biotech pipelines now supply a substantial share of next-generation cancer therapies worldwide.
So please keep track of what is going on in modern Chinese medicine. If they can cure or control diseases like diabetes and cancers do not waste time with useless red tape and 'siapa dapat kontrak'. Just bring these new discoveries into Malaysia at minimal cost so that we too can benefit from the Chinese advances.
The American and European pharmaceuticals may not like it but they are history. Dont worry about them.
